论文信息 - Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer: outcomes in the partially platinum-sensitive (platinum-free interval 6–12 months) subpopulation of OVA-301 phase III randomized trial - 字舞流文

Trabectedin plus pegylated liposomal doxorubicin in relapsed ovarian cancer: outcomes in the partially platinum-sensitive (platinum-free interval 6–12 months) subpopulation of OVA-301 phase III randomized trial

B. Monk | I. Vergote | S. Chan | S. Kaye | B. Kong | N. Colombo | S. Tjulandin | C. Lebedinsky | T. Parekh | V. Alfaro | A. Poveda | H. Hagberg | Y. Park | M. Roy | E. Filipczyk-Cisarż | J. Gómez | Y. Park | Y. Park | I. Vergote | Hans Hagberg | A. Poveda | Javier Gómez | S. B. Kaye | Stephen Chan | Youn C. Park